Blue Sky Legal

As AI continues to advance, the trust gap in performance marketing is only widening. Imagine AI-generated leads that can even answer the phone and pass intake interviews but aren’t real. Devin Downey's latest article explores how AI is reshaping lead quality and why transparency in client acquisition matters now more than ever.

Depo-Provera Lawsuit Update: Potential Mass Tort of 2025? This morning, Joseph Fantini shared an insightful update on the ongoing Depo-Provera litigation, which continues to gain traction in federal courts. By the end of November, over 30 cases are expected to be filed, with significant focus in the Northern District of California and the Southern District of Texas. As we approach the next JPML hearing on December 5, it’s unlikely that an MDL will be formed before the end of this year. Instead, we anticipate Plaintiffs will push for consolidation at the JPML’s first session in early 2025. With over 25 cases expected to be pending in federal courts across the country, meeting the MDL threshold should be no issue. The battle for venue is on the horizon: while Defendants are likely to advocate for consolidation in New York, Plaintiffs are expected to argue for coordination in California—a state home to other major MDLs, including Roundup, Juul, and Facebook. At Blue Sky Legal, we’ve been closely monitoring the case costs, which generally range between $1,300 and $1,700 per signed and law firm vetted claimant. We’re here to support any firms looking to enter or expand their presence in the Depo-Provera litigation. Will Depo-Provera become the defining mass tort of 2025? We’re here to help firms be a part of it.

NEC Litigation Update NEC manufacturers are under increasing legal pressure, following substantial verdicts of $495 million and $60 million in previous cases. The third NEC trial in Missouri State Court is progressing with notable developments. Abbott Laboratories faced a setback when the court blocked their attempt to introduce key statements from federal health agencies. Abbott's defense is now focused on genetic factors and the argument that warnings about risks were unnecessary, but these strategies are encountering significant challenges. A verdict is expected soon, but the real test for Abbott will come in 2025, with three bellwether trials scheduled in the NEC MDL. The legal stakes continue to escalate. #NECLitigation #MassTort #ProductLiability #LegalUpdate #BellwetherTrials #TrialUpdate #LawNews #CourtroomBattles #AbbottLabs #LegalPressure #BlueSkyLegal

I always enjoy my conversations with Dan Miner, as we have found ourselves on the same page about the future of the mass tort industry. Appreciate the spotlight Case Works has shined on our team at Blue Sky Legal. Excited to keep pushing the envelope and spark fresh ideas that will take our field to the next level.

An FCC 1:1 Consent Wake Up Call: 1️⃣ Law firms are at risk of a major compliance issue – When firms buy leads from individuals inquiring about a lawsuit, they often don’t realize those individuals may not know which specific firm will contact them. Without clear proof that the lead consented to be called by your law firm, you could be headed for trouble. 2️⃣ You must have proof that the lead knew they’d be called by your firm – Even if the lead was purchased before January 27, 2025, having their information isn’t enough. You need verifiable proof that the lead consented to being contacted by your law firm or a third party working on your firm’s behalf. 3️⃣ Failing to secure explicit consent could bring legal exposure – If a firm can’t prove that the lead knew they’d be contacted by your specific law firm after the deadline, compliance issues will arise. Buying leads without this consent leaves your firm vulnerable to significant penalties. With the deadline just 100 days away, now is the time to review your processes and ensure every lead is compliant. This oversight is a mistake firms will make if they don’t act now.

Breaking news: Judge Yvonne Gonzalez Rogers has dealt a significant blow to the defense in the social media addiction mass tort case. Her ruling denied the motions from social media giants like Meta, TikTok, and YouTube to dismiss the claims brought by over 40 state Attorneys General. The court found that Section 230 of the Communications Decency Act does not offer these companies the broad protection they were seeking, allowing the litigation to move forward. This decision pushes the case closer to bellwether trials, potentially starting in 2025, which could set major precedents in holding tech companies accountable for their platforms’ addictive designs and the harm caused to young users. With this ruling, now is the ideal time to secure cases while acquisition costs are still favorable. As the litigation progresses and demand increases, costs are expected to rise. Blue Sky Legal specializes in client acquisition for mass torts, and our performance-driven model helps ensure you get signed clients that meet case criteria. Let us help you take advantage of this moment before acquisition costs spike. Reach out to us today to get ahead of the competition and grow your case portfolio efficiently. https://lnkd.in/gTKCTA7z

“There is only trust developed from moving in the same direction together to achieve an optimal result.”

At Blue Sky Legal, we’ve found that acquiring hair relaxer cases typically costs $3K to $4K+. This varies based on media cycles, competition, and other market dynamics. Yet, we’re hearing reports of agencies delivering these cases for as low as $1500. Given the complexities of securing qualified, signed cases, this price point seems questionable. With increasing competition and media costs, we want to ensure that the criteria for these cases are met to the highest standard. Here’s what we’re working with on eligibility: 📝 Key Criteria: 1. Health Conditions: Uterine, Ovarian (various types), and Fallopian Tube Cancer. Excludes: Prior cancer diagnosis, BRCA1/BRCA2 gene mutations, diagnosed before 2013, or clients over 60 at the time of diagnosis. 2. For Death Cases: The date of death must be within 10 years of initial intake. 3. Latency Period: Diagnosis must occur within 10 years after the last use of the product. 4. Treatment Requirements: Clients must have undergone treatments such as chemotherapy, radiation, surgery, or other cancer-related therapies. 5. Product Use: Clients must have used hair relaxers continuously for at least 5 years (minimum of 4 times per year), whether at home or in salons. 6. Brands Under Review: Motions, Dark & Lovely, Soft & Beautiful, Optimum Care, Creme of Nature, Just for Me, Carson Soft Sheen, Olive Oil/ORS. Based on these criteria, we find the $1500 figure difficult to reconcile with the realities of media costs and case complexity. What do you think? 💬 Let’s discuss. Share your thoughts with us at Blue Sky Legal to help bring clarity to this emerging situation.

Depo-Provera Lawsuit: A New Frontier in Mass Tort Litigation With rising concerns over the birth control injection Depo-Provera, law firms are seeing a surge in claims linked to severe side effects, including osteoporosis and bone density issues. As litigation against Pfizer grows, Depo-Provera is becoming a critical focus for law firms across the country. At Blue Sky Legal, we bring unparalleled expertise from similar high-profile cases, such as Essure, where we connected hundreds of claimants to firms just like yours. Our data-driven approach helps you target and acquire qualified claimants efficiently—at scale. Get ahead of the curve with Blue Sky Legal’s mass tort marketing solutions. Contact us today to learn how we can help you navigate the growing Depo-Provera litigation with ease! Read more about the Depo-Provera lawsuit here: https://lnkd.in/gDd_5-DG #DepoProveraLawsuit #MassTortMarketing #ClientAcquisition #BlueSkyLegal #LawFirmMarketing

We love the collaboration between Devin Downey and Case Works CEO Dan Miner. As an industry, we are moving from signed contracts to fully vetted plaintiffs.